Microplastics in the Bronchoalveolar Lavage Fluid of Chinese Children: Associations with Age, City Development, and

Chunzhao Chen1,2, Fang Liu3, Shuting Quan4

  • 1Advanced Interdisciplinary Institute of Environment and Ecology, Beijing Normal University, Zhuhai 519000, China.

PubMed

Insights

Microplastics (MPs) are prevalent in children's lungs, detected in 89.6% of samples. Inhaled MPs, mainly small polymers, were higher in younger children and urban dwellers, suggesting a link to pediatric pulmonary diseases.

Area of Science:

  • Environmental Science
  • Pediatric Pulmonology
  • Toxicology

Background:

  • Microplastic (MP) pollution is a growing global concern.
  • Exposure routes, particularly inhalation, are increasingly recognized.
  • The impact of airborne MPs on pediatric respiratory health remains under-investigated.

Purpose of the Study:

  • To characterize microplastic occurrence in bronchoalveolar lavage fluid (BALF) from children with pulmonary diseases.
  • To identify polymer types, sizes, and factors influencing MP levels in pediatric lungs.
  • To explore potential correlations between MP exposure and pediatric pulmonary conditions.

Main Methods:

  • Bronchoalveolar lavage fluid (BALF) samples were collected from pediatric patients.
  • Microplastics were extracted and characterized using analytical techniques.
  • Statistical analyses were performed to assess MP levels and influencing factors.

Main Results:

  • Microplastics were detected in 89.6% of BALF samples (average 4.31 ± 2.77 items/10 mL).
  • Predominant polymers included polypropylene, polyethylene, and polyester; most MPs were <20 μm.
  • Higher MP levels were observed in younger children, urban residents, and severe community-acquired pneumonia cases.

Conclusions:

  • Inhalation is a significant pathway for airborne MP exposure in pediatric lungs.
  • Age and urban living are associated with increased pulmonary MP burden in children.
  • Further research is warranted to elucidate the relationship between inhaled MPs and pediatric pulmonary diseases.